Allison Jeynes-Ellis
Algemeen Directeur bij Avillion LLP
Vermogen: 51 903 $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Allison Jeynes-Ellis
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
22
| Public Company | Biotechnology | 22 |
Avillion LLP
 Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom.
14
| Holding Company | Pharmaceuticals: Major | 14 |
Anaveon AG
 Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland.
8
| Holding Company | Biotechnology | 8 |
Siolta Therapeutics, Inc.
 Siolta Therapeutics, Inc. BiotechnologyHealth Technology Siolta Therapeutics, Inc. engages in the development of therapeutic microbial consortia to prevent and treat inflammatory diseases. Its pipeline includes STMC-103H, STMC-144M, and STMC-123R. The company was founded by Susan V. Lynch and Nikole E. Kimes in 2016 and is headquartered in San Francisco, CA.
4
| Holding Company | Biotechnology | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Allison Jeynes-Ellis via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Spearhead, LLC | Chief Executive Officer | ||
Abingworth Management Ltd.
 Abingworth Management Ltd. Investment ManagersFinance Abingworth Management Ltd. operates as an investment firm with interests in the life sciences and healthcare sectors. It offers services for businesses in all stages of company development, including early and late-stage venture financing, growth equity, and public companies. The company was founded in 1973 and is headquartered in London, the United Kingdom. | Investment Managers | Corporate Officer/Principal | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Doctorate Degree | |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Private Equity Investor | |
| University of Oxford | College/University | Undergraduate Degree Graduate Degree | |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Undergraduate Degree Doctorate Degree | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Corporate Officer/Principal Private Equity Analyst | |
| McGill University | College/University | Graduate Degree Undergraduate Degree | |
Credit Suisse Securities (Europe) Ltd.
 Credit Suisse Securities (Europe) Ltd. Investment Banks/BrokersFinance Credit Suisse Securities (Europe) Ltd. (Credit Suisse Europe) is the Great Britain-based brokerage subsidiary of Credit Suisse Investment Holdings (UK), itself a subsidiary of Credit Suisse Group AG (SWX: CSGN) in Switzerland. The firm was founded in 1966 and formerly known as Credit Suisse First Boston (Europe) Ltd. Headquartered in London, Credit Suisse Europe arranges financing in international capital markets, provides financial advisory services and acts as a dealer in securities, derivatives and foreign exchange on a principal and agency basis for corporate and institutional investors. | Investment Banks/Brokers | Analyst-Equity | |
| The University of Alabama | College/University | Undergraduate Degree Doctorate Degree | |
| Pepperdine University | College/University | Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Masters Business Admin | |
| University of Maryland | College/University | Graduate Degree Undergraduate Degree | |
| Gensia Sicor Pharmaceuticals, Inc. | Corporate Officer/Principal | ||
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Nutrinia Ltd.
 Nutrinia Ltd. Pharmaceuticals: MajorHealth Technology Nutrinia Ltd. develops bioactive feed supplements for infant formulas and animal feed. The firm is involved in broad intellectual property protection, industrial processes envelopment, conducting additional clinical trials and obtaining regulatory approval for the supplementation of pre-term and infant formulas with Insulin. The company was founded by Naim Shehadeh in 2003 and is headquartered in Ramat-Gan, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Teva Pharmaceuticals Ltd.
 Teva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was incorporated on October 19, 1972 and is headquartered in Castleford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member | |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Chief Executive Officer Director of Finance/CFO Private Equity Investor | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| MIT Sloan School of Management | College/University | Masters Business Admin Masters Business Admin | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
| Pontifax Group | Founder | ||
| Pontifax Management 2 G.P. (2007) Ltd. | Director/Board Member | ||
| Abingworth Avillion Blocker Ltd. | Director/Board Member | ||
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Syncona Investment Management Ltd.
 Syncona Investment Management Ltd. Investment ManagersFinance Syncona Investment Management Ltd. (Syncona) is the asset management subsidiary of Syncona Ltd. in Great Britain. Headquartered in London, the firm was co-founded by Martin Murphy alongside The Wellcome Trust. Syncona is focused on founding, building and funding a portfolio of global leaders in life science. | Investment Managers | Chairman Director of Finance/CFO | |
Ipsen Bioinnovation Ltd.
 Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
| MINK THERAPEUTICS, INC. | Biotechnology | Director/Board Member Investor Relations Contact Chief Executive Officer | |
Syncona Discovery Ltd.
 Syncona Discovery Ltd. Financial ConglomeratesFinance Part of Syncona Ltd., Syncona Discovery Ltd. is a British company that provides investment services. The company is based in London, UK. Syncona Discovery was founded in 2013. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Bond 2 Development 2 Gp Ltd. | Director/Board Member Director/Board Member | ||
| ROYALTY PHARMA PLC | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| AgenTus Therapeutics SA | Director/Board Member Chief Executive Officer | ||
| Nouscom Srl | Miscellaneous Commercial Services | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 20 |
| Verenigd Koninkrijk | 18 |
| Israël | 4 |
| Zwitserland | 3 |
| Frankrijk | 3 |
Sectoraal
| Health Technology | 24 |
| Consumer Services | 12 |
| Finance | 8 |
| Commercial Services | 2 |
Operationeel
| Director/Board Member | 256 |
| Corporate Officer/Principal | 116 |
| Independent Dir/Board Member | 54 |
| Chairman | 43 |
| Chief Executive Officer | 38 |
Sterkste connecties
| Insiders | |
|---|---|
| Samir Kaul | 56 |
| Ran Nussbaum | 38 |
| Martin Murphy | 33 |
| Ted Love | 31 |
| Kurt C. Wheeler | 28 |
| John Bradshaw | 27 |
| Ulf Arne Wiinberg | 26 |
| Anders Gersel Pedersen | 24 |
| David Chiswell | 23 |
| Gary Phillips | 20 |
| Genghis Lloyd-Harris | 19 |
| Paul Clark | 19 |
| Kathryn Gregory | 16 |
| Anderson Timothy | 13 |
| James Reddoch | 12 |
- Beurs
- Insiders
- Allison Jeynes-Ellis
- Bedrijfsconnecties
